Preventing prescription opioid overdose deaths is a public health priority. Deaths from these medications exceed deaths from all illicit drugs combined.1 News reports, actions by states, and congressional legislation that single out the recently approved extended-release hydrocodone product Zohydro ER raise critical questions about the most effective policy needed to reverse the problem.